標(biāo)題: Titlebook: Biomarkers in Cancer; Victor R. Preedy,Vinood B. Patel Living reference work 20200th edition [打印本頁] 作者: Annihilate 時間: 2025-3-21 19:37
書目名稱Biomarkers in Cancer影響因子(影響力)
書目名稱Biomarkers in Cancer影響因子(影響力)學(xué)科排名
書目名稱Biomarkers in Cancer網(wǎng)絡(luò)公開度
書目名稱Biomarkers in Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Biomarkers in Cancer被引頻次
書目名稱Biomarkers in Cancer被引頻次學(xué)科排名
書目名稱Biomarkers in Cancer年度引用
書目名稱Biomarkers in Cancer年度引用學(xué)科排名
書目名稱Biomarkers in Cancer讀者反饋
書目名稱Biomarkers in Cancer讀者反饋學(xué)科排名
作者: 說笑 時間: 2025-3-21 22:43
Biomarkers in Metastatic Colorectal Cancer, cancer. However, this comes at the cost of toxicity to the patient and financial burden to the community. Biomarkers to predict disease course and treatment response are therefore of major importance so as to allow for the judicious selection of treatment candidates and agents and doses. This revie作者: cardiovascular 時間: 2025-3-22 02:40
Biomarkers in Nasopharyngeal Carcinoma and Ionizing Radiation,n the endemic regions including Southern China and Southeast Asia. The primary tumor of NPC is small and usually causes no symptoms. Patients often present with bilateral glands enlargement and local/regional lymph node metastasis leading to poor prognosis and local control rate. Therefore, there is作者: 功多汁水 時間: 2025-3-22 08:02 作者: Analogy 時間: 2025-3-22 11:59
Breast Cancer: Serum TPS as a Biomarker,ctal, and bladder cancer. Cytokeratin reflects the proliferative activity of tumor cells (Barak et al. .)..Tissue polypeptide-specific antigen (TPS) is a cytokeratin marker that quantitates a critical epitope structure of peptide in serum associated with human cytokeratin 18. TPS is detected using t作者: 極端的正確性 時間: 2025-3-22 16:10 作者: 單調(diào)女 時間: 2025-3-22 20:36
Cancer Cardiotoxicity and Cardiac Biomarkers,s, in particular involving heart function. This particular form of cardiotoxicity is related to many factors: age, cumulative dose of the drug administered, drug combination, smoking, prior radiotherapy, and prior cardiovascular disease. Different types of events may manifest: the more important and作者: spinal-stenosis 時間: 2025-3-23 00:18 作者: 結(jié)構(gòu) 時間: 2025-3-23 04:11 作者: 天然熱噴泉 時間: 2025-3-23 09:19
Centrosome Amplification as Biomarkers in Bladder Cancer Using Touch Biopsy and Bladder Washing Cyt summarizes recent urine biomarker developments; and details their implications for prognosis and decision making in non-muscle-invasive bladder cancer (NMIBC). Several urine biomarkers have been reported as FDA-approved adjunctive tests for use in the initial diagnosis of bladder cancer and surveil作者: MAOIS 時間: 2025-3-23 13:06
Circulating Biomarkers in Hodgkin Lymphoma,hese include secondary cancers, cardiopulmonary complications, stroke, peripheral neuropathy, and infertility. In the 20 % of patients who do not respond to first-line agents, prolonged exposure to suboptimal therapy can induce chemoresistance. Patients with a rapid response may be overtreated and m作者: 取消 時間: 2025-3-23 17:34
Circulating Tumor Cells as Biomarkers in Cancer,iciently sensitive to detect very rare cells, there has been a considerable increase in research to improve detection of CTCs. Here we discuss the current technologies employed for the enumeration and characterization of CTCs. The implementation of such technologies has enabled research into determi作者: BOOM 時間: 2025-3-23 20:06
Colorectal Cancer Circulating Biomarkers,eproducibility, and economy. Within circulating biomarkers, we will focus on the detection of autoantibodies in serum from cancer patients and their target tumor-associated antigens (TAAs). Although the sensitivity, specificity, and predictive value of individual TAAs present low scores, the combina作者: Angioplasty 時間: 2025-3-23 22:11 作者: 輕率的你 時間: 2025-3-24 04:44 作者: 不近人情 時間: 2025-3-24 07:56 作者: fibroblast 時間: 2025-3-24 12:21 作者: Jocose 時間: 2025-3-24 15:47
FGFR4 as a Biomarker in Squamous Cell Cancers of the Mouth and Oropharynx, ten most common cancers worldwide, with a large incidence variation according to sex and geographical location. At the moment, no biomarkers are currently available for HNSCC patients; prognosis depends largely on the stage at presentation, with the most important prognostic factor. Fibroblast grow作者: 手段 時間: 2025-3-24 22:24 作者: 痛打 時間: 2025-3-25 01:33
Human Papillomavirus (HPV) Biomarkers in Head and Neck Squamous Cell Carcinoma (HNSCC),o the abuse of tobacco and alcohol. The epidemiological and molecular evidences from recent decades show the human papillomavirus (HPV) to be causative in a subset of HNSCC. Anatomically, HPV exhibits a predilection for the oral cavity and oropharyngeal and laryngeal regions of the head and neck. HP作者: CYN 時間: 2025-3-25 05:00 作者: 漂亮 時間: 2025-3-25 10:42
Forschungsstand zur Europ?isierung cancer. However, this comes at the cost of toxicity to the patient and financial burden to the community. Biomarkers to predict disease course and treatment response are therefore of major importance so as to allow for the judicious selection of treatment candidates and agents and doses. This revie作者: 形容詞詞尾 時間: 2025-3-25 12:58 作者: 傻瓜 時間: 2025-3-25 19:44
https://doi.org/10.1007/978-3-531-91669-9ng to the latest WHO statistics, OSCC accounts for 5 % of the cancer deaths worldwide, being the eighth more lethal cancer entity. Early identification of cancer relapses would have the potentiality to improve the disease control and the patient survival..NeoMark is a European co-funded research pro作者: crumble 時間: 2025-3-25 21:46
Barbara Müller,Christine Schweitzerctal, and bladder cancer. Cytokeratin reflects the proliferative activity of tumor cells (Barak et al. .)..Tissue polypeptide-specific antigen (TPS) is a cytokeratin marker that quantitates a critical epitope structure of peptide in serum associated with human cytokeratin 18. TPS is detected using t作者: Confound 時間: 2025-3-26 03:12
Friedens- und Konfliktforschungthe diagnosis and monitoring of disease in a number of different cancers. Serum carbohydrate antigen 19-9 (CA 19-9) is a biomarker that found utility mainly in biliary tract and pancreatic malignancies as a prognostic marker in monitoring response to treatment and as an indication of disease recurre作者: 宣誓書 時間: 2025-3-26 06:47
Durch Demokratisierung zum stabilen Frieden?s, in particular involving heart function. This particular form of cardiotoxicity is related to many factors: age, cumulative dose of the drug administered, drug combination, smoking, prior radiotherapy, and prior cardiovascular disease. Different types of events may manifest: the more important and作者: 拋物線 時間: 2025-3-26 09:15 作者: 群居男女 時間: 2025-3-26 14:04 作者: Ingest 時間: 2025-3-26 17:48 作者: Melodrama 時間: 2025-3-26 23:13 作者: MODE 時間: 2025-3-27 04:25 作者: cauda-equina 時間: 2025-3-27 07:22 作者: 一小塊 時間: 2025-3-27 10:59
https://doi.org/10.1007/978-3-658-40513-7at is easily detectable in clinical specimens such as blood, sputum, urine, and stool, DNA methylation alterations in tumorigeneses have become one of the promising candidate biomarkers for early detection, prognosis, therapeutic response prediction, and recurrence monitoring in cancer patients. Rec作者: 嗎啡 時間: 2025-3-27 16:40 作者: eczema 時間: 2025-3-27 19:16 作者: 跳動 時間: 2025-3-28 01:00
https://doi.org/10.1007/978-3-658-40513-7conventional carcinoma (CC) probably due to specific features at the invasive front including high-grade tumor budding and cytoplasmic pseudofragments, infiltrating growth pattern, and a weak peritumoral lymphocyte response. SCs also have a different profile of mutations in KRAS or BRAF oncogenes, e作者: Sad570 時間: 2025-3-28 04:18
Anwendung 3: Zielorientiertes Entwerfen, ten most common cancers worldwide, with a large incidence variation according to sex and geographical location. At the moment, no biomarkers are currently available for HNSCC patients; prognosis depends largely on the stage at presentation, with the most important prognostic factor. Fibroblast grow作者: PATHY 時間: 2025-3-28 08:31
https://doi.org/10.1007/978-3-663-08646-8ypes including breast, ovarian, gastric, colorectal, pancreatic, and endometrial cancers. HER2 regulates signaling through several pathways (Ras/Raf/mitogen-activated protein kinase and phosphatidylinositol-3 kinase/protein kinase-B/mammalian target of rapamycin pathways) associated with cell surviv作者: cringe 時間: 2025-3-28 12:41
https://doi.org/10.1007/978-3-322-86928-9o the abuse of tobacco and alcohol. The epidemiological and molecular evidences from recent decades show the human papillomavirus (HPV) to be causative in a subset of HNSCC. Anatomically, HPV exhibits a predilection for the oral cavity and oropharyngeal and laryngeal regions of the head and neck. HP作者: 鉆孔 時間: 2025-3-28 17:43 作者: 禍害隱伏 時間: 2025-3-28 21:32
Biomarkers in Disease: Methods, Discoveries and Applicationshttp://image.papertrans.cn/b/image/187806.jpg作者: AGONY 時間: 2025-3-28 23:09 作者: 有法律效應(yīng) 時間: 2025-3-29 07:02
HER2 as Biomarker for Endometrial Cancer, gene with chemoresistance and overall poor survival. Immunotherapy with monoclonal antibodies targeting HER2 as well as the use of novel tyrosine kinase inhibitors targeting the erbB pathway may hold promise for patients harboring these biologically aggressive endometrial neoplasms.作者: 小隔間 時間: 2025-3-29 10:38 作者: Kindle 時間: 2025-3-29 12:56 作者: incubus 時間: 2025-3-29 15:45 作者: 網(wǎng)絡(luò)添麻煩 時間: 2025-3-29 23:48 作者: 妨礙議事 時間: 2025-3-30 00:54 作者: GROUP 時間: 2025-3-30 05:27 作者: Mercurial 時間: 2025-3-30 09:54
Biomarkers in Metastatic Colorectal Cancer,eatment response are therefore of major importance so as to allow for the judicious selection of treatment candidates and agents and doses. This review seeks to summarize the current markers available for the prediction of prognosis and treatment response in metastatic colorectal cancer.作者: 責(zé)難 時間: 2025-3-30 15:39
Epigenetics and Biomarkers in Lung Cancer: Emerging Blood-Based Molecular Biomarkers for Detection merging blood-based molecular biomarkers that have been evaluated for the detection and monitoring of lung cancer. We specially focus on biomarkers based on a non-invasive liquid biopsy approach, such as circulating tumor cells (CTCs), circulating miRNAs, gene promoter methylation, and DNA mutations in cell-free circulating DNA.作者: 主動 時間: 2025-3-30 19:09
https://doi.org/10.1007/978-3-663-10515-2mor metastasis, patient survival and resistance to therapy. This chapter provides an overview of the evidence regarding the existence and function of CD133 in breast cancers in the context of the experimental and clinical data. It also discusses CD133 as a possible target for breast cancer therapy.作者: 親密 時間: 2025-3-31 00:23
https://doi.org/10.1007/978-3-658-40513-7 in comparison with others, and their status in applications of DNA methylation biomarkers in cancer. The research field of DNA methylation biomarking is evolving rapidly with promising results that have the potential to confer enormous benefits for cancer patients in the future.作者: compose 時間: 2025-3-31 02:58 作者: 閑聊 時間: 2025-3-31 08:28 作者: Brain-Imaging 時間: 2025-3-31 11:53 作者: Commodious 時間: 2025-3-31 14:59 作者: garrulous 時間: 2025-3-31 20:32
Biomarkers in Nasopharyngeal Carcinoma and Ionizing Radiation,cript. In addition to diagnosis value, EBER, EBNA1, and LMP1 levels in tissue after radiation therapy could serve as biomarkers to evaluate response to radiotherapy. In light of the detection of EBV DNA in plasma, serum, nasal brush, and saliva, EBV DNA is particularly useful for periodic monitoring作者: 去才蔑視 時間: 2025-4-1 01:11
Biomarkers in NeoMark European Project for Oral Cancers,tecture of the project is based on the following key points:.The NeoMark system was trained and initially validated in a multicenter pilot study (three European clinical centers involved: two in Italy and one in Spain) basing on 86 patients affected by OSCC with a minimum follow-up of 12 months..The作者: entreat 時間: 2025-4-1 04:35
Breast Cancer: Serum TPS as a Biomarker,nformation and establishing patient responses to therapy. A main limitation of TPS is that it is not “organ specific,” which impedes diagnostic utility. Additionally, TPS levels are altered according to inflammation conditions, such as liver cirrhosis, ovulation, and menopausal status. Further clini作者: 胰臟 時間: 2025-4-1 08:58
CA 19-9 as a Serum Biomarker in Cancer, used most commonly as a biomarker in pancreatic cancer as a prognostic and predictive tool and less commonly in other malignancies. This chapter will focus mainly on utility of CA 19-9 in pancreatic cancer and biliary tract cancers.作者: 粗魯性質(zhì) 時間: 2025-4-1 11:27
Cancer Cardiotoxicity and Cardiac Biomarkers,ike targeted therapy (i.e., trastuzumab) or angiogenesis inhibitors are all associated with some form of cardiac toxicity: while targeted drugs may induce a reversible damage, angiogenesis inhibitors have a prothrombotic activity, which leads to a high incidence of thromboembolic events..Patients we作者: CROAK 時間: 2025-4-1 17:19
Carcinoembryonic Antigen-Family Cell Adhesion Molecules (CEACAM) as Colorectal Cancer Biomarkers,tigen (CEA) is the biomarker most frequently used in colorectal cancer. It is effective in the surveillance of colorectal cancer patients and in monitoring the efficacy of therapy, whereas it is less useful in colorectal screening. Recent studies indicate that also CEA-related proteins (CEACAMs) are作者: 卡死偷電 時間: 2025-4-1 19:35
Centrosome Amplification as Biomarkers in Bladder Cancer Using Touch Biopsy and Bladder Washing Cytand Ki-67 (MIB-1) overexpression and UroVysion (multicolor fluorescence in situ hybridization kit for detecting copy number aberrations in chromosomes 3, 7, and 17, and the 9p21 locus), are promising for predicting disease progression and tumor recurrence in NMIBC. Further validation with a prospect作者: Trabeculoplasty 時間: 2025-4-2 01:56
Circulating Biomarkers in Hodgkin Lymphoma,Although PET/CT is currently the most important tool used, interpretation is imperfect with low false-negative rates countered by high false positives. Furthermore, PET/CT is unavailable in many rural or underprivileged centers and, even in the most advantaged centers, is impractical for frequent te作者: 法律 時間: 2025-4-2 03:51
Circulating Tumor Cells as Biomarkers in Cancer,aggressive adjuvant therapy. Furthermore, various studies have shown that temporal monitoring of CTCs can be used to evaluate patient responses to therapy and to detect genetic and phenotypic changes to tumors in real time, allowing more effective treatment guidance.作者: oblique 時間: 2025-4-2 07:19
